brand logo

Am Fam Physician. 2022;105(3):236-237

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

Clinical Question

Do mobile phone–based interventions help patients adhere to medication regimens for hypertension and hypercholesterolemia for primary cardiovascular disease prevention?

Evidence-Based Answer

Mobile phone–based interventions improve adherence to cardiovascular medication regimens and may improve blood pressure control, but there is no patient-oriented evidence that these interventions are beneficial.1 (Strength of Recommendation: C, based on disease-oriented evidence.)

Practice Pointers

Cardiovascular disease is a leading cause of mortality in the United States. In 2020, the National Vital Statistics System listed heart disease and stroke as the top and third leading causes of death, respectively.2 Management of risk factors, including hypertension and hyperlipidemia, can help prevent cardiovascular disease; however, patient nonadherence to cardiovascular medication regimens can contribute to suboptimal management. The authors of this Cochrane review sought to demonstrate whether mobile phone–based interventions increase patient compliance with cardiovascular medication regimens.

This Cochrane review included 25,633 participants and 14 randomized controlled trials conducted in Europe, Asia, South Africa, and North and South America.1 Participants received prescriptions for medications tailored to the prevention of cardiovascular disease and were recruited from primary and tertiary clinics, community outreach programs, and home visits. Interventions used mobile phones, and study duration was at least one year. Mobile phone interventions were compared with usual care, which often included verbal counseling and written information, and in one study consisted of text messages that included only general health information on lifestyle and diet but did not include information on how to manage specific diseases. The authors evaluated disease-oriented outcomes such as medication adherence and blood pressure and cholesterol levels, as well as patient-oriented outcomes such as patient satisfaction with treatment, cardiovascular disease events, and adverse events.

Most trials were subject to a high risk of bias, and the results were inconsistent. Only two studies were similar enough to allow meta-analysis. In these studies, the intervention groups received motivational and educational text messages that focused on blood pressure control and medication benefits. The intervention groups demonstrated increased adherence to blood pressure medication regimens (pooled odds ratio = 1.32; 95% CI, 1.06 to 1.65) compared with groups who received handouts or text messages with general healthy lifestyle information not specific to blood pressure control. Targeted text messaging in this comparison modestly improved the mean systolic blood pressure (mean decrease = 1.55 mm Hg; 95% CI, −0.25 to 3.36).

Seven studies compared intervention groups using targeted text messages as an adjunct to blood pressure management and focused on controlled blood pressure as an outcome. All studies were at high risk of bias because of design and intervention inconsistencies. Each of the studies demonstrated a positive but not statistically significant trend from the use of targeted text messaging compared with usual care, although the degree of difference in some studies was negligible (odds ratio = 1.01; 95% CI, 0.76 to 1.34). Thirteen studies described systolic blood pressure as an outcome and compared mobile phone interventions with usual care. Four of those studies evaluated smartphone delivery of targeted text messages and follow-up calls for blood pressure management. These studies noted statistically significant improvements in systolic pressures compared with patients who received usual care, with reductions ranging from 4.70 to 12.45 mm Hg. However, one study revealed that phone consultations in addition to text messages with disease recommendation summaries and follow-up appointment reminders resulted in a small increase in systolic blood pressure (2.80 mm Hg; 95% CI, 0.30 to 5.30).

In five studies, reduction of low-density lipoprotein cholesterol was the targeted outcome. Results could not be meta-analyzed in two of the studies because of study population and intervention heterogeneity. The authors found that usual care combined with mobile phone interventions, including pharmacist-led motivational interviewing and text messages with recommendations and clinical practice guidelines for hyperlipidemia treatment, regimen modifications, and follow-up visits, resulted in small reductions of questionable clinical significance in low-density lipoprotein cholesterol (9.2 mg per dL [0.24 mmol per L] in one study and 5.3 mg per dL [0.14 mmol per L] in the other) compared with usual care alone. In three other studies, the addition of mobile phone–based interventions did not improve outcomes. Patient satisfaction did not improve when mobile phone interventions were added to usual care, and there were no significant adverse events from the use of these interventions.

Already a member/subscriber?  Log In

Subscribe

From $145
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available

Article Only

$25.95
  • Immediate, unlimited access to just this article
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Continue Reading

More in AFP

More in Pubmed

Copyright © 2022 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.